000 01630 a2200457 4500
005 20250516140359.0
264 0 _c20130827
008 201308s 0 0 eng d
022 _a1545-5017
024 7 _a10.1002/pbc.24507
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYamada, Kayo
245 0 0 _aFeasibility of reduced-intensity allogeneic stem cell transplantation with imatinib in children with philadelphia chromosome-positive acute lymphoblastic leukemia.
_h[electronic resource]
260 _bPediatric blood & cancer
_cAug 2013
300 _aE60-2 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBenzamides
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aFemale
650 0 4 _aHematopoietic Stem Cell Transplantation
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
650 0 4 _aMale
650 0 4 _aPhiladelphia Chromosome
650 0 4 _aPiperazines
_xadministration & dosage
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xtherapy
650 0 4 _aPyrimidines
_xadministration & dosage
650 0 4 _aRemission Induction
650 0 4 _aTransplantation, Homologous
700 1 _aYasui, Masahiro
700 1 _aKondo, Osamu
700 1 _aSato, Maho
700 1 _aSawada, Akihisa
700 1 _aKawa, Keisei
700 1 _aInoue, Masami
773 0 _tPediatric blood & cancer
_gvol. 60
_gno. 8
_gp. E60-2
856 4 0 _uhttps://doi.org/10.1002/pbc.24507
_zAvailable from publisher's website
999 _c22560454
_d22560454